Literature DB >> 11701449

Effects of growth hormone on renal tubular handling of sodium in healthy humans.

T K Hansen1, J Møller, K Thomsen, E Frandsen, R Dall, J O Jørgensen, J S Christiansen.   

Abstract

To investigate the mechanisms behind the water- and sodium-retaining effects of growth hormone (GH), we studied the effect of GH on 1) water and sodium homeostasis, 2) the renin-angiotensin-aldosterone system (RAAS), and 3) lithium clearance (C(Li)) with and without concomitant prostaglandin (PG) synthesis inhibition with ibuprofen. GH administration for 6 days induced a significant increase in plasma renin, which was abolished by coadministration of ibuprofen (mU x l(-1) x 24 h(-1): control: 22.4 +/- 4.3; GH: 37.7 +/- 8.8; ibuprofen: 15.2 +/- 3.0; GH + ibuprofen: 19.7 +/- 2.5; ANOVA: P < 0.01). Comparable increments in extracellular volume were seen after 6-day treatment with GH alone and in combination with ibuprofen [liters: control, 19.57 +/- 0.92; GH, 20.80 +/- 1.00 (ANOVA: P < 0.0005); ibuprofen, 19.38 +/- 0.90; GH + ibuprofen, 21.63 +/- 1.37 (ANOVA: P < 0.0005)]. Treatment with GH increased C(Li) and changed the tubular handling of sodium and water. The absolute distal sodium reabsorption was increased, and this was only partially counterbalanced by decreased reabsorption in the proximal tubules. The data demonstrate that GH-induced activation of the RAAS can be blocked by concomitant PG synthesis inhibition and that the tubular effects of GH include increased distal nephron sodium and water reabsorption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701449     DOI: 10.1152/ajpendo.2001.281.6.E1326

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  15 in total

Review 1.  Regulated sodium transport in the renal connecting tubule (CNT) via the epithelial sodium channel (ENaC).

Authors:  Johannes Loffing; Christoph Korbmacher
Journal:  Pflugers Arch       Date:  2009-03-11       Impact factor: 3.657

Review 2.  Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.

Authors:  Ana M Ramos-Leví; Mónica Marazuela
Journal:  Endocrine       Date:  2017-01-02       Impact factor: 3.633

3.  Downregulation of the ACE2/Ang-(1-7)/Mas axis in transgenic mice overexpressing GH.

Authors:  Marina C Muñoz; Valeria Burghi; Johanna G Miquet; Jorge F Giani; Ricardo D Banegas; Jorge E Toblli; Yimin Fang; Feiya Wang; Andrzej Bartke; Fernando P Dominici
Journal:  J Endocrinol       Date:  2014-04-22       Impact factor: 4.286

4.  Differential regulation of GHRH-receptor and GHS-receptor expression by long-term in vitro treatment of ovine pituitary cells with GHRP-2 and GHRH.

Authors:  Sang-Gun Roh; Maria Doconto; Dan Dan Feng; Chen Chen
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

5.  Urinary calcium excretion and insulin resistance in patients with acromegaly.

Authors:  Alexandre Braga Libório; Patrícia R L Figueiredo; Renan M Montenegro Junior; Renan M Montenegro; Manoel R A Martins; Geraldo B Silva Junior; Ivna Aguiar Porto; José Italo Soares Mota; Elizabeth Daher
Journal:  Int Urol Nephrol       Date:  2012-01-11       Impact factor: 2.370

Review 6.  Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.

Authors:  Rosario Pivonello; Renata S Auriemma; Ludovica F S Grasso; Claudia Pivonello; Chiara Simeoli; Roberta Patalano; Mariano Galdiero; Annamaria Colao
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

7.  Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly.

Authors:  Peter Kamenicky; Say Viengchareun; Anne Blanchard; Geri Meduri; Philippe Zizzari; Martine Imbert-Teboul; Alain Doucet; Philippe Chanson; Marc Lombès
Journal:  Endocrinology       Date:  2008-04-03       Impact factor: 4.736

Review 8.  Management of acromegaly: is there a role for primary medical therapy?

Authors:  Zachary M Bush; Mary Lee Vance
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 9.  Pathogenesis and prevalence of hypertension in acromegaly.

Authors:  M Bondanelli; M R Ambrosio; E C degli Uberti
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

10.  Electrolyte Imbalance in Patients with Sheehan's Syndrome.

Authors:  Chur Hoan Lim; Ji Hyun Han; Joon Jin; Ji Eun Yu; Jin Ook Chung; Dong Hyeok Cho; Dong Jin Chung; Min Young Chung
Journal:  Endocrinol Metab (Seoul)       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.